Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-01 @ 12:17 AM
Study NCT ID:
NCT02574260
Status:
COMPLETED
Last Update Posted:
2015-12-17
First Post:
2015-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)
Sponsor:
BioVex Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-18
First Submit QC Date:
None
Study First Post Date:
2015-10-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-13
Results First Submit QC Date:
None
Results First Post Date:
2015-12-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-13
Last Update Post Date:
2015-12-17
Last Update Post Date Type:
ESTIMATED